Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature

[1] Chan TM(2000)Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong–Guangzhou Nephrology Study Group N Engl J Med 343 1156-1162

[2] Li FK(2005)Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy Rheumatology 44 386-389

[3] Tang CS(2000)Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases J Rheumatol 27 1542-1545

[4] Majithia V(2006)Mycophenolate mofetil in dermatomyositis: is it safe? Neurology 66 1245-1247

[5] Harisdangkul V(2004)Self-resolution of Epstein–Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate J Am Acad Dermatol 51 S124-S130

[6] Gelber AC(2006)Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis Arch Dermatol 142 65-69

[7] Nousari HC(2004)Refractory polymyositis responding to infliximab: extended follow-up Rheumatology 43 531-532

[8] Wigley FM(2000)Etanercept is effective in the treatment of polymyositis/dermatomyositis which is refractory to conventional therapy including steroid and other disease modifying agents Arthritis Rheum 43 S193-15

[9] Rowin J(2003)Anti-TNF blockade with infliximab (Remicade) in polymyositis and dermatomyositis Eur Neurol 50 10-1199

[10] Amato AA(2004)Refractory polymyositis responding to infliximab Rheumatology 43 1198-563

[1] Chan TM(2000)Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong–Guangzhou Nephrology Study Group N Engl J Med 343 1156-1162

[2] Li FK(2005)Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy Rheumatology 44 386-389

[3] Tang CS(2000)Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases J Rheumatol 27 1542-1545

[4] Majithia V(2006)Mycophenolate mofetil in dermatomyositis: is it safe? Neurology 66 1245-1247

[5] Harisdangkul V(2004)Self-resolution of Epstein–Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate J Am Acad Dermatol 51 S124-S130

[6] Gelber AC(2006)Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis Arch Dermatol 142 65-69

[7] Nousari HC(2004)Refractory polymyositis responding to infliximab: extended follow-up Rheumatology 43 531-532

[8] Wigley FM(2000)Etanercept is effective in the treatment of polymyositis/dermatomyositis which is refractory to conventional therapy including steroid and other disease modifying agents Arthritis Rheum 43 S193-15

[9] Rowin J(2003)Anti-TNF blockade with infliximab (Remicade) in polymyositis and dermatomyositis Eur Neurol 50 10-1199

[10] Amato AA(2004)Refractory polymyositis responding to infliximab Rheumatology 43 1198-563